Cargando…
Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients
Previous studies have indicated that carcinoembryonic antigen (CEA) and cancer antigen 15–3 (CA15-3) levels are both independent prognostic factors in breast cancer. However, the utility of CEA and CA15-3 levels as conventional cancer biomarkers in patients with triple-negative breast cancer (TNBC)...
Autores principales: | Dai, Danian, Chen, Bo, Tang, Hailin, Wang, Bin, Zhao, Zhiping, Xie, Xiaoming, Wei, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999206/ https://www.ncbi.nlm.nih.gov/pubmed/27561099 http://dx.doi.org/10.1371/journal.pone.0161902 |
Ejemplares similares
-
Prognostic Values Of Preoperative Serum CEA And CA125 Levels And Nomograms For Young Breast Cancer Patients
por: Li, Xuan, et al.
Publicado: (2019) -
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
por: Ebeling, F G, et al.
Publicado: (2002) -
Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer
por: Chen, Bo, et al.
Publicado: (2016) -
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment
por: Bartsch, Rupert, et al.
Publicado: (2006) -
The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients
por: Kuang, Jiaan, et al.
Publicado: (2020)